TScan Therapeutics Inc. (TCRX)
1.26
-0.01 (-0.79%)
At close: Apr 02, 2025, 3:59 PM
1.25
-0.79%
After-hours: Apr 02, 2025, 07:28 PM EDT
13F Institute Ownership
Total Institutes of 88 in TScan Therapeutics expanded their positions with an increase of 2 investors compared to the previous quarter. A reduction of 302.3K shares, as total invested capital declined by $82.08M with ownership percentage dropping from 35.24% to 34.99%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 4.51% | 5.36M | +2.54% | 16.29M | 6.11% |
| Ecor1 Capital, LLC | 4.21% | 5M | +0.00% | 15.2M | 0.57% |
| Blackrock, Inc. | 4.18% | 4.96M | +7.10% | 15.08M | < 0.01% |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.